This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The central underlying hypothesis in this proposal is that gene expression changes in a surrogate tissue (leukocytes), induced either as a primary or secondary result of the disease processes, and which may not directly reflect gene expression in the brain, can be utilized to form an overall multi-gene classifier of Alzheimer's disease (AD). If this hypothesis is correct, the pattern of gene expression from this surrogate, peripheral tissue could form the basis of a diagnostic signature of AD. This proposal is based on the current literature plus some pilot data the investigators have obtained. The objectives of the study are as follows: 1) To collect blood leukocytes from 30 AD patients and 30 age-matched control subjects over the two-year period of this project. 2) Employ Affymetrix GeneChip micro-array technology to measure simultaneously the expression levels of up to 14,000 genes transcribed in leukocytes derived from the blood of the AD patient and control subjects. 3) To analyze the leukocyte gene expression datasets collected during this proposal, using hierarchical clustering and supervised learning algorithms to identify and validate patterns of gene expression (multi-gene signatures) that differentiate AD subjects from age-matched healthy controls. A total of 60 subjects will be recruited: 30 AD patients with a confirmed diagnosis of probable AD, and 30 age-matched control subjects. All subjects (both AD patients and control subjects) will be recruited though the Clinical Core Resource within the Alzheimer's Disease Research Center (ADRC), Silberstein Institute for Aging and Dementia. The study team will obtain informed consent, and a 15ml blood sample will be collected from each subject prior to initial medication. Blood samples will be processed to isolate and purify the leukocytes and the samples will then be stored prior to RNA purification, cRNA synthesis and GeneChip hybridization and scanning. Gene Expression data from the proposed study will be analyzed by ANOVA testing, and by employing hierarchical clustering, and supervised learning algorithms.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000096-45
Application #
7378344
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2006-04-01
Project End
2007-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
45
Fiscal Year
2006
Total Cost
$18,237
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Homann, O R; Misura, K; Lamas, E et al. (2016) Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness. Mol Psychiatry 21:1690-1695
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Li, Yi; Tsui, Wai; Rusinek, Henry et al. (2015) Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease. J Nucl Med 56:270-3
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23
Beecham, Gary W; Dickson, Dennis W; Scott, William K et al. (2015) PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84:972-80

Showing the most recent 10 out of 470 publications